Gene · 574456
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Semaphorin-3A in autoimmune rheumatic diseases: immunological and pathological aspects. | Inflammopharmacology | 2025 | 40759850 | PubTator, text mining | PubMed |
| Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques. | J Pharm Anal | 2025 | 40757000 | PubTator, text mining | PubMed |
Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration. | PLoS One | 2025 | 40748972 | PubTator, text mining | PubMed |
| Inhibition of miR-615-3p enhances dentinogenesis in scaps via PVT1-mediated mitochondrial regulation. | Stem Cell Res Ther | 2025 | 40745571 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma. | J Cell Mol Med | 2025 | 40736417 | PubTator, text mining | PubMed |
| Correction: MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. | Oncogene | 2025 | 40461851 | PubTator, text mining | PubMed |
| Carotid Plaque-Derived Small Extracellular Vesicles Mediate Atherosclerosis and Correlate With Plaque Vulnerability. | MedComm (2020) | 2025 | 40391195 | PubTator, text mining | PubMed |
| Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance. | Front Bioeng Biotechnol | 2025 | 40370595 | PubTator, text mining | PubMed |
| Impact of MiRNAs on Wnt-related gene activity in breast cancer. | Sci Rep | 2025 | 40346182 | PubTator, text mining | PubMed |
| Laboratory-based Biomarkers for Risk Prediction, Auxiliary Diagnosis and Post-operative Follow-up of Osteoporotic Fractures. | Curr Osteoporos Rep | 2025 | 40199776 | PubTator, text mining | PubMed |
| Methods for Extracellular Vesicle Isolation: Relevance for Encapsulated miRNAs in Disease Diagnosis and Treatment. | Genes (Basel) | 2025 | 40149481 | PubTator, text mining | PubMed |
| Kaempferol Induces DNA Damage in Colorectal Cancer Cells by Regulating the MiR-195/miR-497-PFKFB4-Mediated Nonoxidative Pentose Phosphate Pathway. | J Agric Food Chem | 2025 | 40091822 | PubTator, text mining | PubMed |
| Network study of miRNA regulating traumatic heterotopic ossification. | PLoS One | 2025 | 39932915 | PubTator, text mining | PubMed |
| Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer. | Sci Rep | 2025 | 39905036 | PubTator, text mining | PubMed |
| Comprehensive analysis of ceRNA Networks in UCEC: Prognostic and therapeutic implications. | PLoS One | 2025 | 39883704 | PubTator, text mining | PubMed |
| High Glucose-Induced Senescent Fibroblasts-Derived Exosomal miR-497 Inhibits Wound Healing by Regulating Endothelial Cellular Autophagy via ATG13. | Anal Cell Pathol (Amst) | 2025 | 39831298 | PubTator, text mining | PubMed |
| Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients. | J ECT | 2025 | 39792703 | PubTator, text mining | PubMed |
| Exploring the ceRNA network involving AGAP2-AS1 as a novel biomarker for preeclampsia. | Sci Rep | 2024 | 39521940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574456/papers?page=3